Genetic and Metabolic Predispositions: Understanding Your Individual Response Pilot weight management success depends partly on individual metabolic factors and genetic predispositions in GLP-1 and related peptide pathways
The peak in 2022 corresponds to GLP-1 drug sales hitting $22 billion, with the approval of semaglutide by the FDA in 2021 and the initiation of the first clinical trial for an oral diabetes drug based on GLP-1 in the same year
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia, a sweeping new study suggests
Additionally, electronic health records may have diagnostic coding errors that would impact the results of the analysis.
In the gnomAD database 15 , the rs10305420 T allele is most common in the European (40%) and Middle Eastern (38%) ancestry groups, followed by the Admixed American (28%), South Asian (20%) and East Asian (16%) ancestry groups, and least common in the African (7%) ancestry group
